EX-99.1 2 algm-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

Allegro MicroSystems Reports Second Quarter 2025 Results

– Sales Increased 12% Sequentially to $187 Million –

 

Manchester, NH, October 31, 2024 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its second quarter ended September 27, 2024.

“We delivered results in-line with our commitments. Second quarter sales were $187 million, with sequential growth in both Automotive and Industrial and Other end markets. Non-GAAP EPS was $0.08, at the high end of our outlook,” said Vineet Nargolwala, President and CEO of Allegro. “We are encouraged by the continued demand for our differentiated solutions and the progress made by our customers and partners to rebalance their inventories. We continue to invest for growth to extend our market leadership. The accelerating pace of our new product introductions, as evidenced by our latest product releases, sets the stage for significant growth momentum in the near future.”

 

Second Quarter Financial Highlights:

In thousands, except per share data

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Automotive

 

$

141,893

 

 

$

131,184

 

 

$

197,321

 

 

$

273,077

 

 

$

382,751

 

Industrial and other

 

 

45,498

 

 

 

35,735

 

 

 

78,188

 

 

 

81,233

 

 

 

171,051

 

Total net sales

 

$

187,391

 

 

$

166,919

 

 

$

275,509

 

 

$

354,310

 

 

$

553,802

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

45.7

%

 

 

44.8

%

 

 

57.9

%

 

 

45.3

%

 

 

57.3

%

Operating margin %

 

 

2.2

%

 

 

(6.4

)%

 

 

26.5

%

 

 

(1.9

)%

 

 

25.9

%

Diluted EPS

 

$

(0.18

)

 

$

(0.09

)

 

$

0.34

 

 

$

(0.27

)

 

$

0.65

 

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

48.8

%

 

 

48.8

%

 

 

58.3

%

 

 

48.8

%

 

 

58.1

%

Operating margin %

 

 

11.7

%

 

 

6.0

%

 

 

31.3

%

 

 

9.0

%

 

 

31.0

%

Diluted EPS

 

$

0.08

 

 

$

0.03

 

 

$

0.40

 

 

$

0.11

 

 

$

0.79

 

Business Outlook

For the third quarter of fiscal year 2025 ending December 27, 2024, the Company expects net sales to be in the range of $170 million to $180 million. This outlook comprehends continued progress toward vehicle electrification and ongoing inventory rebalancing as reflected in the latest third-party estimates, as well as typical December quarter seasonality. The Company also estimates the following results on a non-GAAP basis:

Gross Margin is expected to be between 49% and 51%,
The Company made a voluntary $25 million payment on its term loan facility on October 31, 2024 and now expects Interest Expense to be approximately $6 million, and
Diluted Earnings per Share are expected to be between $0.04 and $0.08.

 

Allegro has not provided a reconciliation of its third fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Interest Expense, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.


Earnings Webcast

A webcast will be held on Thursday, October 31, 2024 at 8:30 a.m., Eastern Time. Vineet Nargolwala, President and Chief Executive Officer, and Derek P. D’Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits (“ICs”) and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro’s diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power saving technologies for data centers and clean energy applications.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 29, 2024, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the "SEC"). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix, customer mix or channel mix, which could negatively impact our gross margin; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control impacting us, our key suppliers or our manufacturing partners; our ability to develop new product features or new products in a timely and cost-effective manner; our ability to manage growth; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers’ quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to effectively manage our growth and to retain key and highly skilled personnel; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property


rights; disruptions or breaches of our information technology systems or confidential information or those of our third-party service providers; our principal stockholders has substantial control over us; anti-takeover provisions in our organizational documents and under the General Corporation Law of the State of Delaware; any failure to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; the physical, transition and litigation risks presented by climate change; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their nearest GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

Net sales

 

$

187,391

 

 

$

275,509

 

 

$

354,310

 

 

$

553,802

 

Cost of goods sold

 

 

101,729

 

 

 

116,006

 

 

 

193,877

 

 

 

236,349

 

Gross profit

 

 

85,662

 

 

 

159,503

 

 

 

160,433

 

 

 

317,453

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

43,510

 

 

 

43,428

 

 

 

88,714

 

 

 

86,403

 

Selling, general and administrative

 

 

38,085

 

 

 

43,160

 

 

 

78,282

 

 

 

87,389

 

Total operating expenses

 

 

81,595

 

 

 

86,588

 

 

 

166,996

 

 

 

173,792

 

Operating income (loss)

 

 

4,067

 

 

 

72,915

 

 

 

(6,563

)

 

 

143,661

 

Interest and other (expense) income

 

 

(12,398

)

 

 

156

 

 

 

(18,341

)

 

 

(2,486

)

Loss on change in fair value of forward repurchase contract

 

 

(34,752

)

 

 

 

 

 

(34,752

)

 

 

 

(Loss) income before income taxes

 

 

(43,083

)

 

 

73,071

 

 

 

(59,656

)

 

 

141,175

 

Income tax (benefit) provision

 

 

(9,470

)

 

 

7,400

 

 

 

(8,430

)

 

 

14,615

 

Net (loss) income

 

 

(33,613

)

 

 

65,671

 

 

 

(51,226

)

 

 

126,560

 

Net income attributable to non-controlling interests

 

 

62

 

 

 

54

 

 

 

124

 

 

 

93

 

Net (loss) income attributable to Allegro MicroSystems, Inc.

 

$

(33,675

)

 

$

65,617

 

 

$

(51,350

)

 

$

126,467

 

Net (loss) income per common share attributable to Allegro MicroSystems, Inc.:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.18

)

 

$

0.34

 

 

$

(0.27

)

 

$

0.66

 

Diluted

 

$

(0.18

)

 

$

0.34

 

 

$

(0.27

)

 

$

0.65

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

189,182,850

 

 

 

192,431,094

 

 

 

191,324,281

 

 

 

192,214,210

 

Diluted

 

 

189,182,850

 

 

 

195,100,855

 

 

 

191,324,281

 

 

 

195,055,495

 

 

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited condensed consolidated statements of operations:

 

Three-Month Period Ended

 

 

Change

 

 

Six-Month Period Ended

 

 

Change

 

 

September 27, 2024

 

 

September 29, 2023

 

 

Amount

 

 

%

 

 

September 27, 2024

 

 

September 29, 2023

 

 

Amount

 

 

%

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

Automotive

 

$

141,893

 

 

$

197,321

 

 

$

(55,428

)

 

 

(28

)%

 

$

273,077

 

 

$

382,751

 

 

$

(109,674

)

 

 

(29

)%

Industrial and other

 

 

45,498

 

 

 

78,188

 

 

 

(32,690

)

 

 

(42

)%

 

 

81,233

 

 

 

171,051

 

 

 

(89,818

)

 

 

(53

)%

Total net sales

 

$

187,391

 

 

$

275,509

 

 

$

(88,118

)

 

 

(32

)%

 

$

354,310

 

 

$

553,802

 

 

$

(199,492

)

 

 

(36

)%

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

September 27,

 

 

March 29,

 

 

2024
(Unaudited)

 

 

2024

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

188,751

 

 

$

212,143

 

Restricted cash

 

 

10,287

 

 

 

10,018

 

Trade accounts receivable, net

 

 

76,985

 

 

 

118,508

 

Inventories

 

 

176,648

 

 

 

162,302

 

Prepaid income taxes

 

 

38,636

 

 

 

31,908

 

Prepaid expenses and other current assets

 

 

32,253

 

 

 

33,584

 

Current portion of related party notes receivable

 

 

 

 

 

3,750

 

Total current assets

 

 

523,560

 

 

 

572,213

 

Property, plant and equipment, net

 

 

325,051

 

 

 

321,175

 

Deferred income tax assets

 

 

61,839

 

 

 

54,496

 

Goodwill

 

 

203,151

 

 

 

202,425

 

Intangible assets, net

 

 

266,753

 

 

 

276,854

 

Related party notes receivable, less current portion

 

 

 

 

 

4,688

 

Equity investment in related party

 

 

30,186

 

 

 

26,727

 

Other assets

 

 

81,577

 

 

 

72,025

 

Total assets

 

$

1,492,117

 

 

$

1,530,603

 

Liabilities, Non-Controlling Interests and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Trade accounts payable

 

$

50,245

 

 

$

35,964

 

Amounts due to related party

 

 

5,546

 

 

 

1,626

 

Accrued expenses and other current liabilities

 

 

62,742

 

 

 

76,389

 

Current portion of long-term debt

 

 

5,475

 

 

 

3,929

 

Total current liabilities

 

 

124,008

 

 

 

117,908

 

Long-term debt

 

 

396,056

 

 

 

249,611

 

Other long-term liabilities

 

 

33,345

 

 

 

31,368

 

Total liabilities

 

 

553,409

 

 

 

398,887

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

1,840

 

 

 

1,932

 

Additional paid-in capital

 

 

993,988

 

 

 

694,332

 

(Accumulated deficit) retained earnings

 

 

(31,931

)

 

 

463,012

 

Accumulated other comprehensive loss

 

 

(26,583

)

 

 

(28,841

)

Equity attributable to Allegro MicroSystems, Inc.

 

 

937,314

 

 

 

1,130,435

 

Non-controlling interests

 

 

1,394

 

 

 

1,281

 

Total stockholders’ equity

 

 

938,708

 

 

 

1,131,716

 

Total liabilities, non-controlling interests and stockholders’ equity

 

$

1,492,117

 

 

$

1,530,603

 

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(33,613

)

 

$

65,671

 

 

$

(51,226

)

 

$

126,560

 

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

15,997

 

 

 

15,080

 

 

 

32,455

 

 

 

29,353

 

Amortization of deferred financing costs

 

 

306

 

 

 

73

 

 

 

1,087

 

 

 

107

 

Deferred income taxes

 

 

(2,796

)

 

 

(9,772

)

 

 

(7,795

)

 

 

(18,134

)

Stock-based compensation

 

 

11,545

 

 

 

10,877

 

 

 

21,663

 

 

 

21,919

 

Loss on change in fair value of forward repurchase contract

 

 

34,752

 

 

 

 

 

 

34,752

 

 

 

 

Provisions for inventory and expected credit losses

 

 

2,111

 

 

 

4,239

 

 

 

4,488

 

 

 

9,422

 

Change in fair value of marketable securities

 

 

 

 

 

(72

)

 

 

 

 

 

3,579

 

Other non-cash reconciling items

 

 

6,563

 

 

 

43

 

 

 

6,577

 

 

 

43

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

(13,717

)

 

 

2,676

 

 

 

41,417

 

 

 

(7,645

)

Inventories

 

 

(2,845

)

 

 

(3,274

)

 

 

(18,831

)

 

 

(31,221

)

Prepaid expenses and other assets

 

 

(14,093

)

 

 

(6,253

)

 

 

(15,808

)

 

 

(16,453

)

Trade accounts payable

 

 

13,470

 

 

 

(15,736

)

 

 

13,670

 

 

 

2,695

 

Due to and from related parties

 

 

695

 

 

 

(3,990

)

 

 

4,132

 

 

 

6,112

 

Accrued expenses and other current and long-term liabilities

 

 

(2,828

)

 

 

(12,832

)

 

 

(16,838

)

 

 

(29,944

)

Net cash provided by operating activities

 

 

15,547

 

 

 

46,730

 

 

 

49,743

 

 

 

96,393

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(9,972

)

 

 

(31,191

)

 

 

(20,949

)

 

 

(76,101

)

Sales of marketable securities

 

 

 

 

 

6,204

 

 

 

 

 

 

16,175

 

Net cash used in investing activities

 

 

(9,972

)

 

 

(24,987

)

 

 

(20,949

)

 

 

(59,926

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Loan made to affiliate

 

 

 

 

 

(4,000

)

 

 

 

 

 

(4,000

)

Net proceeds from Refinanced 2023 Term Loan Facility

 

 

193,483

 

 

 

 

 

 

193,483

 

 

 

 

Payment of borrowings under 2023 Term Loan Facility

 

 

 

 

 

 

 

 

(50,000

)

 

 

 

Finance lease payments

 

 

(240

)

 

 

 

 

 

(385

)

 

 

 

Receipts on related party notes receivable

 

 

937

 

 

 

937

 

 

 

1,875

 

 

 

1,875

 

Payments for taxes related to net share settlement of equity awards

 

 

(1,126

)

 

 

(1,669

)

 

 

(12,297

)

 

 

(14,091

)

Proceeds from issuance of common stock under employee stock purchase plan

 

 

1,987

 

 

 

 

 

 

1,987

 

 

 

1,899

 

Repurchases of common stock

 

 

(853,805

)

 

 

 

 

 

(853,805

)

 

 

 

Net proceeds from issuance of common stock

 

 

665,850

 

 

 

 

 

 

665,850

 

 

 

 

Payment of debt issuance costs

 

 

 

 

 

 

 

 

 

 

 

(1,450

)

Net cash provided by (used in) financing activities

 

 

7,086

 

 

 

(4,732

)

 

 

(53,292

)

 

 

(15,767

)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

 

2,200

 

 

 

(901

)

 

 

1,375

 

 

 

(974

)

Net increase (decrease) in cash and cash equivalents and restricted cash

 

 

14,861

 

 

 

16,110

 

 

 

(23,123

)

 

 

19,726

 

Cash and cash equivalents and restricted cash at beginning of period

 

 

184,177

 

 

 

362,321

 

 

 

222,161

 

 

 

358,705

 

Cash and cash equivalents and restricted cash at end of period:

 

$

199,038

 

 

$

378,431

 

 

$

199,038

 

 

$

378,431

 

 


Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP Financial Measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision, non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as percentage of net sales (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP Financial Measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related party activities and other non-operational costs.

Non-GAAP Income Tax Provision

In calculating non-GAAP Income Tax Provision, we have added back the following to GAAP Income Tax Provision:

Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below and elimination of discrete tax adjustments.

 

Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Gross Profit

 

$

85,662

 

 

$

74,771

 

 

$

159,503

 

 

$

160,433

 

 

$

317,453

 

GAAP Gross Margin (% of net sales)

 

 

45.7

%

 

 

44.8

%

 

 

57.9

%

 

 

45.3

%

 

 

57.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

10

 

 

 

(1

)

 

 

 

 

 

9

 

 

 

 

Purchased intangible amortization

 

 

4,875

 

 

 

4,875

 

 

 

273

 

 

 

9,750

 

 

 

675

 

Restructuring costs

 

 

16

 

 

 

1,200

 

 

 

 

 

 

1,216

 

 

 

 

Stock-based compensation

 

 

817

 

 

 

561

 

 

 

946

 

 

 

1,378

 

 

 

3,552

 

Total Non-GAAP Adjustments

 

$

5,718

 

 

$

6,635

 

 

$

1,219

 

 

$

12,353

 

 

$

4,227

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Gross Profit

 

$

91,380

 

 

$

81,406

 

 

$

160,722

 

 

$

172,786

 

 

$

321,680

 

Non-GAAP Gross Margin (% of net sales)

 

 

48.8

%

 

 

48.8

%

 

 

58.3

%

 

 

48.8

%

 

 

58.1

%

 


 

Reconciliation of Non-GAAP Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28, 2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Expenses

 

$

81,595

 

 

$

85,401

 

 

$

86,588

 

 

$

166,996

 

 

$

173,792

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and Development Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Research and Development Expenses

 

 

43,510

 

 

 

45,204

 

 

 

43,428

 

 

 

88,714

 

 

 

86,403

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

206

 

 

 

1,029

 

 

 

2

 

 

 

1,235

 

 

 

9

 

Restructuring costs

 

 

260

 

 

 

169

 

 

 

 

 

 

429

 

 

 

 

Stock-based compensation

 

 

3,523

 

 

 

3,735

 

 

 

3,602

 

 

 

7,258

 

 

 

6,470

 

Other costs(1)

 

 

3

 

 

 

 

 

 

 

 

 

3

 

 

 

 

Non-GAAP Research and Development Expenses

 

 

39,518

 

 

 

40,271

 

 

 

39,824

 

 

 

79,789

 

 

 

79,924

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Selling, General and Administrative Expenses

 

 

38,085

 

 

 

40,197

 

 

 

43,160

 

 

 

78,282

 

 

 

87,389

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

275

 

 

 

814

 

 

 

1,804

 

 

 

1,089

 

 

 

4,876

 

Purchased intangible amortization

 

 

535

 

 

 

535

 

 

 

357

 

 

 

1,070

 

 

 

715

 

Restructuring costs

 

 

2,046

 

 

 

1,045

 

 

 

 

 

 

3,091

 

 

 

 

Stock-based compensation

 

 

7,205

 

 

 

5,822

 

 

 

6,329

 

 

 

13,027

 

 

 

11,897

 

Other costs(1)

 

 

(1,820

)

 

 

811

 

 

 

100

 

 

 

(1,009

)

 

 

100

 

Non-GAAP Selling, General and Administrative Expenses

 

 

29,844

 

 

 

31,170

 

 

 

34,570

 

 

 

61,014

 

 

 

69,801

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Non-GAAP Adjustments

 

 

12,233

 

 

 

13,960

 

 

 

12,194

 

 

 

26,193

 

 

 

24,067

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Expenses

 

$

69,362

 

 

$

71,441

 

 

$

74,394

 

 

$

140,803

 

 

$

149,725

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 

 


Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Income (Loss)

 

$

4,067

 

 

$

(10,630

)

 

$

72,915

 

 

$

(6,563

)

 

$

143,661

 

GAAP Operating Margin (% of net sales)

 

 

2.2

%

 

 

(6.4

)%

 

 

26.5

%

 

 

(1.9

)%

 

 

25.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

491

 

 

 

1,842

 

 

 

1,806

 

 

 

2,333

 

 

 

4,885

 

Purchased intangible amortization

 

 

5,410

 

 

 

5,410

 

 

 

630

 

 

 

10,820

 

 

 

1,390

 

Restructuring costs

 

 

2,322

 

 

 

2,414

 

 

 

 

 

 

4,736

 

 

 

 

Stock-based compensation

 

 

11,545

 

 

 

10,118

 

 

 

10,877

 

 

 

21,663

 

 

 

21,919

 

Other costs(1)

 

 

(1,817

)

 

 

811

 

 

 

100

 

 

 

(1,006

)

 

 

100

 

Total Non-GAAP Adjustments

 

$

17,951

 

 

$

20,595

 

 

$

13,413

 

 

$

38,546

 

 

$

28,294

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Income

 

$

22,018

 

 

$

9,965

 

 

$

86,328

 

 

$

31,983

 

 

$

171,955

 

Non-GAAP Operating Margin (% of net sales)

 

 

11.7

%

 

 

6.0

%

 

 

31.3

%

 

 

9.0

%

 

 

31.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 

Reconciliation of EBITDA and Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Net (Loss) Income

 

$

(33,613

)

 

$

(17,613

)

 

$

65,671

 

 

$

(51,226

)

 

$

126,560

 

GAAP Net (Loss) Income Margin (% of net sales)

 

 

(17.9

)%

 

 

(10.6

)%

 

 

23.8

%

 

 

(14.5

)%

 

 

22.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

10,353

 

 

 

5,377

 

 

 

758

 

 

 

15,730

 

 

 

1,527

 

Interest income

 

 

(420

)

 

 

(494

)

 

 

(850

)

 

 

(914

)

 

 

(1,693

)

Income tax (benefit) provision

 

 

(9,470

)

 

 

1,040

 

 

 

7,400

 

 

 

(8,430

)

 

 

14,615

 

Depreciation & amortization

 

 

15,997

 

 

 

16,458

 

 

 

15,145

 

 

 

32,455

 

 

 

29,418

 

EBITDA

 

$

(17,153

)

 

$

4,768

 

 

$

88,124

 

 

$

(12,385

)

 

$

170,427

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

3,295

 

 

 

1,842

 

 

 

1,806

 

 

 

5,137

 

 

 

4,885

 

Restructuring costs

 

 

2,067

 

 

 

2,414

 

 

 

 

 

 

4,481

 

 

 

 

Stock-based compensation

 

 

11,545

 

 

 

10,118

 

 

 

10,877

 

 

 

21,663

 

 

 

21,919

 

Loss on change in fair value of forward repurchase contract

 

 

34,752

 

 

 

 

 

 

 

 

 

34,752

 

 

 

 

Other costs(1)

 

 

(2,195

)

 

 

2,807

 

 

 

1,301

 

 

 

612

 

 

 

5,890

 

Adjusted EBITDA

 

$

32,311

 

 

$

21,949

 

 

$

102,108

 

 

$

54,260

 

 

$

203,121

 

Adjusted EBITDA Margin (% of net sales)

 

 

17.2

%

 

 

13.1

%

 

 

37.1

%

 

 

15.3

%

 

 

36.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 


Reconciliation of Non-GAAP Profit before Tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP (Loss) Income before Income Taxes

 

$

(43,083

)

 

$

(16,573

)

 

$

73,071

 

 

$

(59,656

)

 

$

141,175

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

3,295

 

 

 

1,842

 

 

 

1,806

 

 

 

5,137

 

 

 

4,885

 

Transaction-related interest

 

 

141

 

 

 

709

 

 

 

 

 

 

850

 

 

 

 

Purchased intangible amortization

 

 

5,410

 

 

 

5,410

 

 

 

630

 

 

 

10,820

 

 

 

1,390

 

Restructuring costs

 

 

2,067

 

 

 

2,414

 

 

 

 

 

 

4,481

 

 

 

 

Stock-based compensation

 

 

11,545

 

 

 

10,118

 

 

 

10,877

 

 

 

21,663

 

 

 

21,919

 

Loss on change in fair value of forward repurchase contract

 

 

34,752

 

 

 

 

 

 

 

 

 

34,752

 

 

 

 

Other costs(1)

 

 

1,428

 

 

 

2,807

 

 

 

1,301

 

 

 

4,235

 

 

 

5,890

 

Total Non-GAAP Adjustments

 

$

58,638

 

 

$

23,300

 

 

$

14,614

 

 

$

81,938

 

 

$

34,084

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Profit before Tax

 

$

15,555

 

 

$

6,727

 

 

$

87,685

 

 

$

22,282

 

 

$

175,259

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Income Tax Provision and Non-GAAP Effective Tax Rate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Income Tax (Benefit) Provision

 

$

(9,470

)

 

$

1,040

 

 

$

7,400

 

 

$

(8,430

)

 

$

14,615

 

GAAP effective tax rate

 

 

22.0

%

 

 

(6.3

)%

 

 

10.1

%

 

 

14.1

%

 

 

10.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of adjustments to GAAP results

 

 

10,071

 

 

 

(395

)

 

 

2,554

 

 

 

9,676

 

 

 

6,380

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Income Tax Provision

 

$

601

 

 

$

645

 

 

$

9,954

 

 

$

1,246

 

 

$

20,995

 

Non-GAAP effective tax rate

 

 

3.9

%

 

 

9.6

%

 

 

11.4

%

 

 

5.6

%

 

 

12.0

%

 


 

Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc.(1)

 

$

(33,675

)

 

$

(17,675

)

 

$

65,617

 

 

$

(51,350

)

 

$

126,467

 

GAAP Basic weighted average common shares

 

 

189,182,850

 

 

 

193,465,708

 

 

 

192,431,094

 

 

 

191,324,281

 

 

 

192,214,210

 

GAAP Diluted weighted average common shares

 

 

189,182,850

 

 

 

193,465,708

 

 

 

195,100,855

 

 

 

191,324,281

 

 

 

195,055,495

 

GAAP Basic (Loss) Earnings per Share

 

$

(0.18

)

 

$

(0.09

)

 

$

0.34

 

 

$

(0.27

)

 

$

0.66

 

GAAP Diluted (Loss) Earnings per Share

 

$

(0.18

)

 

$

(0.09

)

 

$

0.34

 

 

$

(0.27

)

 

$

0.65

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

3,295

 

 

 

1,842

 

 

 

1,806

 

 

 

5,137

 

 

 

4,885

 

Transaction-related interest

 

 

141

 

 

 

709

 

 

 

 

 

 

850

 

 

 

 

Purchased intangible amortization

 

 

5,410

 

 

 

5,410

 

 

 

630

 

 

 

10,820

 

 

 

1,390

 

Restructuring costs

 

 

2,067

 

 

 

2,414

 

 

 

 

 

 

4,481

 

 

 

 

Stock-based compensation

 

 

11,545

 

 

 

10,118

 

 

 

10,877

 

 

 

21,663

 

 

 

21,919

 

Loss on change in fair value of forward repurchase contract

 

 

34,752

 

 

 

 

 

 

 

 

 

34,752

 

 

 

 

Other costs(2)

 

 

1,428

 

 

 

2,807

 

 

 

1,301

 

 

 

4,235

 

 

 

5,890

 

Total Non-GAAP Adjustments

 

 

58,638

 

 

 

23,300

 

 

 

14,614

 

 

 

81,938

 

 

 

34,084

 

Tax effect of adjustments to GAAP results(3)

 

 

(10,071

)

 

 

395

 

 

 

(2,554

)

 

 

(9,676

)

 

 

(6,380

)

Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc.

 

$

14,892

 

 

$

6,020

 

 

$

77,677

 

 

$

20,912

 

 

$

154,171

 

Basic weighted average common shares

 

 

189,182,850

 

 

 

193,465,708

 

 

 

192,431,094

 

 

 

191,324,281

 

 

 

192,214,210

 

Diluted weighted average common shares

 

 

189,710,595

 

 

 

194,705,716

 

 

 

195,100,855

 

 

 

192,154,185

 

 

 

195,055,495

 

Non-GAAP Basic Earnings per Share

 

$

0.08

 

 

$

0.03

 

 

$

0.40

 

 

$

0.11

 

 

$

0.80

 

Non-GAAP Diluted Earnings per Share

 

$

0.08

 

 

$

0.03

 

 

$

0.40

 

 

$

0.11

 

 

$

0.79

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc. represents GAAP Net (Loss) Income adjusted for Net Income Attributable to non-controlling interests.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.

 

(3) To calculate the tax effect of adjustments to GAAP results, the Company considers each Non-GAAP adjustment by tax jurisdiction and reverses all discrete items to calculate an annual Non-GAAP effective tax rate (“NG ETR”). This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.

 

 


 

Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 27, 2024

 

 

June 28,
2024

 

 

September 29, 2023

 

 

September 27, 2024

 

 

September 29, 2023

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Cash Flow

 

$

15,547

 

 

$

34,196

 

 

$

46,730

 

 

$

49,743

 

 

$

96,393

 

GAAP Operating Cash Flow (% of net sales)

 

 

8.3

%

 

 

20.5

%

 

 

17.0

%

 

 

14.0

%

 

 

17.4

%

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(9,972

)

 

 

(10,977

)

 

 

(31,191

)

 

 

(20,949

)

 

 

(76,101

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Free Cash Flow

 

$

5,575

 

 

$

23,219

 

 

$

15,539

 

 

$

28,794

 

 

$

20,292

 

Non-GAAP Free Cash Flow (% of net sales)

 

 

3.0

%

 

 

13.9

%

 

 

5.6

%

 

 

8.1

%

 

 

3.7

%

Investor Contact:

Jalene Hoover

VP of Investor Relations & Corporate Communications

+1 (512) 751-6526

jhoover@allegromicro.com